Edesa Biotech GAAP EPS of -$0.25

4 hours ago 2

Edesa Biotech press release (NASDAQ:EDSA): Q3 GAAP EPS of -$0.25.
At June 30, 2025, Edesa had cash and cash equivalents of $12.4 million and working capital of $12.1 million.

Recommended For You